Our scRNA-Seq atlas analysis of TIME in vivo revealed that inhibition of ZEB1 not only increased the CD8+ T cell population but also decreased the proportion of granulocytes (neutrophils) and their interaction with tumor cells (Figure 4A and Supplemental Figure 1). The gene discussed is CD8A; the disease is neoplasm.